Kennedy Lawrence T. Jr 4

4 · BIODESIX INC · Filed Jan 5, 2023

Form 4

Period: 2023-01-03

Director10% Owner

Transactions

Award
Restricted Stock Units
2023-01-03+91,463→ 91,463 total
→ Common Stock (91,463 underlying)
Award
Restricted Stock Units
2023-01-03+27,408→ 27,408 total
→ Common Stock (27,408 underlying)
Award
Stock Options (Right to Buy)
2023-01-03+124,998→ 124,998 total
Exercise: $2.05Exp: 2033-01-02→ Common Stock (124,998 underlying)

Footnotes (5)

[F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer common stock.
[F2]These RSUs will vest in full on January 3, 2024, generally subject to the Reporting Person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.
[F3]These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date, and have no expiration date.
[F4]Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.
[F5]This option vests 40% on January 3, 2025, and the remaining 60% in 36 successive, equal monthly installments measured from January 3, 2025, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date.

Documents

1 file